Search research articles
Contact Us
Filters
Showing results (121-130 of 204) with videos related to
Page
of 21
Sort By:
Journal of Biomedical Nanotechnology
|
January 31, 2018
3D Poly(Lactic-co-glycolic acid) Scaffolds for Treating Spinal Cord Injury
Fangfang Sun, Tingchun Shi, Tao Zhou, et al.
RMD Open
|
October 26, 2022
Safety and efficacy of the SGLT2 inhibitor dapagliflozin in patients with systemic lupus erythematosus: a phase I/II trial
Huijing Wang, Ting Li, Fangfang Sun, et al.
Cell Reports
|
February 13, 2020
Hepatic DNAJB9 Drives Anabolic Biasing to Reduce Steatosis and Obesity
Fangfang Sun, Yilie Liao, Xingfan Qu, et al.
Molecules (Basel, Switzerland)
|
September 28, 2024
Ionic Liquid/Deep Eutectic Solvent-Mediated Calcining Synthesis of Cobalt-Based Electrocatalysts for Water Splitting
Chenyun Zhang, Jianjiao Jin, Jiahao Wang, et al.
International Journal of Food Microbiology
|
August 21, 2019
Identification of human pathogenic Enterocytozoon bieneusi, Cyclospora cayetanensis, and Cryptosporidium parvum on the surfaces of vegetables and fruits in Henan, China
Junqiang Li, Ke Shi, Fangfang Sun, et al.
Frontiers in Microbiology
|
November 22, 2021
Application of Lab-on-Chip for Detection of Microbial Nucleic Acid in Food and Environment
Liu Yang, Wei Yi, Fangfang Sun, et al.
AIDS (London, England)
|
January 28, 2025
Safety and efficacy of switching to 4-weekly albuvirtide plus daily dolutegravir in virologically suppressed HIV-1 adults: a 24-week study
Xiaoxin Xie, Yanhua Fu, Lin Gan, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
|
December 22, 2025
Safety, pharmacokinetics, and efficacy of albuvirtide administered by intravenous bolus every 4 weeks in combination with oral dolutegravir in virologically suppressed adults living with HIV: A 24-week study
Yanhua Fu, Xiaoxin Xie, Lin Gan, et al.
Annals of the Rheumatic Diseases
|
November 7, 2025
Low-dose belimumab reduced risk of flares in patients with systemic lupus erythematosus: a multicentre, randomised, double-blind, placebo-controlled trial
Fangfang Sun, Huijing Wang, Danting Zhang, et al.
Journal of Biomedical Nanotechnology
|
September 25, 2013
Guided bone regeneration using a flexible hydroxyapatite patch
Fangfang Sun, Hyun Gu Kang, Su-Chak Ryu, et al.
Page
of 21
Search research articles
Search
Showing results (121-130 of 204) with videos related to
Sort By:
Page
of 21
Journal of Biomedical Nanotechnology
|
January 31, 2018
3D Poly(Lactic-co-glycolic acid) Scaffolds for Treating Spinal Cord Injury
Fangfang Sun, Tingchun Shi, Tao Zhou, et al.
RMD Open
|
October 26, 2022
Safety and efficacy of the SGLT2 inhibitor dapagliflozin in patients with systemic lupus erythematosus: a phase I/II trial
Huijing Wang, Ting Li, Fangfang Sun, et al.
Cell Reports
|
February 13, 2020
Hepatic DNAJB9 Drives Anabolic Biasing to Reduce Steatosis and Obesity
Fangfang Sun, Yilie Liao, Xingfan Qu, et al.
Molecules (Basel, Switzerland)
|
September 28, 2024
Ionic Liquid/Deep Eutectic Solvent-Mediated Calcining Synthesis of Cobalt-Based Electrocatalysts for Water Splitting
Chenyun Zhang, Jianjiao Jin, Jiahao Wang, et al.
International Journal of Food Microbiology
|
August 21, 2019
Identification of human pathogenic Enterocytozoon bieneusi, Cyclospora cayetanensis, and Cryptosporidium parvum on the surfaces of vegetables and fruits in Henan, China
Junqiang Li, Ke Shi, Fangfang Sun, et al.
Frontiers in Microbiology
|
November 22, 2021
Application of Lab-on-Chip for Detection of Microbial Nucleic Acid in Food and Environment
Liu Yang, Wei Yi, Fangfang Sun, et al.
AIDS (London, England)
|
January 28, 2025
Safety and efficacy of switching to 4-weekly albuvirtide plus daily dolutegravir in virologically suppressed HIV-1 adults: a 24-week study
Xiaoxin Xie, Yanhua Fu, Lin Gan, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
|
December 22, 2025
Safety, pharmacokinetics, and efficacy of albuvirtide administered by intravenous bolus every 4 weeks in combination with oral dolutegravir in virologically suppressed adults living with HIV: A 24-week study
Yanhua Fu, Xiaoxin Xie, Lin Gan, et al.
Annals of the Rheumatic Diseases
|
November 7, 2025
Low-dose belimumab reduced risk of flares in patients with systemic lupus erythematosus: a multicentre, randomised, double-blind, placebo-controlled trial
Fangfang Sun, Huijing Wang, Danting Zhang, et al.
Journal of Biomedical Nanotechnology
|
September 25, 2013
Guided bone regeneration using a flexible hydroxyapatite patch
Fangfang Sun, Hyun Gu Kang, Su-Chak Ryu, et al.
Page
of 21